Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)
China flag China · Delayed Price · Currency is CNY
28.99
+1.08 (3.87%)
At close: Feb 13, 2026

SHE:300878 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
263.08253.96330.16162.74280.8595.23
Trading Asset Securities
10-245.56---
Cash & Short-Term Investments
273.08253.96575.73162.74280.8595.23
Cash Growth
-15.79%-55.89%253.77%-42.04%-52.83%269.97%
Accounts Receivable
132.42165.71264.97333.89409.9299.68
Other Receivables
14.9252.1529.1366.312.762.85
Receivables
147.34217.87294.07700.2412.65302.52
Inventory
83.56118.32153.78116.78129.4982.31
Other Current Assets
29.0426.3328.1654.2747.1518.56
Total Current Assets
533.01616.481,0521,034870.09998.62
Property, Plant & Equipment
819.76853.66857.39761.5706.09548.95
Long-Term Investments
252526.552519.9619.96
Goodwill
10.8910.9727.0827.2217.62-
Other Intangible Assets
32.2633.5935.6737.5639.3130.07
Long-Term Deferred Tax Assets
43.5654.6727.0716.6324.596.12
Long-Term Deferred Charges
3.492.515.076.117.038.73
Other Long-Term Assets
20.0255.4431.176.528.6216.34
Total Assets
1,4881,6522,0621,9151,6931,629
Accounts Payable
65.6978.85101.1295.7597.26115.67
Accrued Expenses
5.5844.7452.0924.6153.263.74
Short-Term Debt
-10.01261.9257.2550.0614.71
Current Portion of Long-Term Debt
90.7888.21----
Current Portion of Leases
-2.5510.2111.7612.29-
Current Income Taxes Payable
17.510.140.262.336.0912.4
Current Unearned Revenue
20.8911.1814.715.798.394.35
Other Current Liabilities
27.554.75.285.585.122.77
Total Current Liabilities
228.01240.38445.55413.07232.4213.65
Long-Term Debt
182.12186.62149.9533.39--
Long-Term Leases
3.085.1813.1816.7119.99-
Long-Term Unearned Revenue
37.8438.9242.8332.6525.0126.08
Long-Term Deferred Tax Liabilities
7.327.42.037.676.894.66
Total Liabilities
458.37478.5653.55503.49284.28244.39
Common Stock
144.79144.79144.79144.7980.4480.44
Additional Paid-In Capital
680.77680.77680.77680.77745.12745.12
Retained Earnings
238.37382.11565.05572.29571.76555.7
Treasury Stock
-50-50----
Total Common Equity
1,0141,1581,3911,3981,3971,381
Minority Interest
15.7116.1617.613.211.713.13
Shareholders' Equity
1,0301,1741,4081,4111,4091,384
Total Liabilities & Equity
1,4881,6522,0621,9151,6931,629
Total Debt
275.97292.57435.24319.182.3414.71
Net Cash (Debt)
-2.89-38.61140.48-156.36198.46580.51
Net Cash Growth
-----65.81%-
Net Cash Per Share
-0.02-0.270.94-1.091.384.82
Filing Date Shares Outstanding
142.05142.05144.79144.79144.79144.79
Total Common Shares Outstanding
142.05142.05144.79144.79144.79144.79
Working Capital
305.01376.1606.19620.93637.69784.97
Book Value Per Share
7.148.159.609.659.659.54
Tangible Book Value
970.771,1131,3281,3331,3401,351
Tangible Book Value Per Share
6.837.849.179.219.269.33
Buildings
-728.27408.8344.26239.09106.98
Machinery
-264.87307.22286.89162.9689.79
Construction In Progress
-55.1270.43225.09366.57422.36
Source: S&P Global Market Intelligence. Standard template. Financial Sources.